Citation

  • Authors: Sharma S. et al.
  • Year: 2022
  • Journal: Hum Mutat
  • Applications: in vitro / DNA, DsiRNA / INTERFERin, jetPRIME
  • Cell types:
    1. Name: Daoy
      Description: Human desmoplastic cerebellar medulloblastoma cells
    2. Name: HEK-293
      Description: Human embryonic kidney Fibroblast
      Known as: HEK293, 293

Method

HEK-293 and DAOY cells grown in 24-well plates were transfected with 60 nM of control or CIC-L DsiRNAs (Dicer-substrate short interfering RNAs) using INTERFERin (Polyplus-transfection). HEK-293 were transfected using jetPRIME (Polyplus-transfection) for plasmids DNA.

Abstract

Heterozygous pathogenic variants in CIC, which encodes a transcriptional repressor, have been identified in individuals with neurodevelopmental phenotypes. To date, 11 CIC variants have been associated with the CIC-related neurodevelopmental syndrome. Here, we describe three novel and one previously reported CIC variants in four individuals with neurodevelopmental delay. Notably, we report for the first time a de novo frameshift variant specific to the long isoform of CIC (CIC-L, NM_001304815.1:c.1100dup, p.Pro368AlafsTer16) in an individual with speech delay, intellectual disability, and autism spectrum disorder. Our investigation into the function of CIC-L reveals that partial loss of CIC-L leads to transcriptional derepression of CIC target genes. We also describe a missense variant (NM_015125.3:c.683G>A, p.Arg228Gln) in an individual with a history of speech delay and relapsed pre-B acute lymphoblastic leukemia. Functional studies of this variant suggest a partial loss of CIC transcriptional repressor activity. Our study expands the list of CIC pathogenic variants and contributes to the accumulating evidence that CIC haploinsufficiency or partial loss of function is a pathogenic mechanism causing neurodevelopmental phenotypes.

Go to